Paper - WANFANG MED ONLINE

You Position: Home > Paper

Progress in platelets and chronic obstructive pulmonary disease

( views:69, downloads:8 )

Author:: No author available

Journal Title:: Chinese Journal of Tuberculosis and Respiratory Diseases

Issue:: 10

DOI:: 10.3760/cma.j.cn112147-20220425-00349

Key Word:: No keyword available

Abstract： Platelets-related pathophysiological mechanism and clinical research is one of the research hot topics in chronic obstructive pulmonary disease (COPD) at home and abroad. Increasing evidence has proved the association between thrombocytosis and COPD. Platelets activation interacts with COPD. Antiplatelet therapy has been shown to have significant effects on both short-term and long-term outcomes in COPD. Platelets inhibition may be an emerging therapeutic target for COPD, and antiplatelet therapy is expected to become an inexpensive and effective treatment for COPD. This article reviewed the research progress in platelets and COPD.

Reference

[1]潘磊,杨渝浩,董德琼.慢性阻塞性肺疾病急性加重期患者血浆选择素相关蛋白水平的观察[J].2010,(4).
[2].Sites of reactive oxygen species generation by mitochondria oxidizing different substrates[J].2013,1(1).
[3].慢性阻塞性肺疾病诊治指南（2021年修订版）[J].2021,(3).
[4]Maha Fathy,Mohamed,Asmaa,Ali,Ahmad,Abbas,etc.Mean platelet volume as a predictor of pulmonary hypertension in patients with stable COPD.[J].2019,14.
[5]Philip, Toner,Danny Francis, McAuley,Murali, Shyamsundar.Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome.[J].2015,19.
[6]Ashraf, Fawzy,Nirupama, Putcha,Laura M, Paulin,etc.Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.[J].2018,19(1).
[7]Adam J,Bia?as,Karolina,Siewiera,Cezary,Wata?a,etc.Mitochondrial functioning abnormalities observed in blood platelets of chronic smoke-exposed guinea pigs - a pilot study.[J].2018,13.
[8]Aleva, Floor E.,Temba, Godfrey,de Mast, Quirijn,etc.Increased Platelet-Monocyte Interaction in Stable COPD in the Absence of Platelet Hyper-Reactivity[J].2018,95(1).
[9]S, Chen,Y, Su,J, Wang.ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation.[J].2013,4.
[10]Hai-Jian Guo,Feng Jiang,Chu Chen,etc.Plasma brain natriuretic peptide, platelet parameters, and cardiopulmonary function in chronic obstructive pulmonary disease[J].2021,(36).
[11]Yin W,Ghebrehiwet B,Peerschke EI.Platelet mediated complement activation.[J].2008,632(0).
[12]D, Zucker-Franklin,C S, Philipp.Platelet production in the pulmonary capillary bed: new ultrastructural evidence for an old concept.[J].2000,157(1).
[13].A Longitudinal Cohort Study of Aspirin Use and Progression of Emphysema-like Lung Characteristics on CT Imaging: The MESA Lung Study.[J].2017,(Spec).
[14]J, Hung,J Y, Lam,L, Lacoste,etc.Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin.[J].1995,92(9).
[15]Maclay JD,MacNee W,Raftis J,etc.Increased platelet activation in patients with stable and acute exacerbation of COPD.[J].2011,66(9).
[16]Tadahiro, Goto,Mohammad Kamal, Faridi,Carlos A, Camargo,etc.The association of aspirin use with severity of acute exacerbation of chronic obstructive pulmonary disease: a retrospective cohort study.[J].2018,28(1).
[17]Gawaz M,Langer H,May AE.Platelets in inflammation and atherogenesis.[J].2005,115(12).
[18]Susheel N,Chaurasia,Geeta,Kushwaha,Paresh P,Kulkarni,etc.Platelet HIF-2α promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release.[J].2019.
[19]Tabuchi A,Kuebler WM.Endothelium-platelet interactions in inflammatory lung disease.[J].2008,49(4/6).
[20]Alvar,Agustí,James C,Hogg.Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease.[J].2019,381(13).
[21]Agustí, Alvar.Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype.[J].2012,7(5).
[22]Harrison,M.T.,Short,P.,Williamson,P.A.,etc.Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: A role for antiplatelet therapy?[J].2014,69(7).
[23]Craig N. Morrell,Angela A. Aggrey,Lesley M. Chapman,etc.Emerging roles for platelets as immune and inflammatory cells[J].2014,123(18).
[24]Anne-Mette, Hvas.Platelet Function in Thrombosis and Hemostasis.[J].2016,(3).
[25]van der Meijden, Paola E. J.,Heemskerk, Johan W. M..Platelet biology and functions: new concepts and clinical perspectives[J].2019,16(3).
[26]Hamid, U.,Krasnodembskaya, A.,Fitzgerald, M.,etc.Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS[J].2017,72(11).
[27]Lefrançais Emma,Ortiz-Muñoz Guadalupe,Caudrillier Axelle,etc.The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors[J].2017,544(7648).
[28]CaoYuan, Yao,XiaoLi, Liu,Ze, Tang.Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.[J].2017,12(Spec ).
[29]A, Szczeklik,M, Krzanowski,P, Góra,etc.Antiplatelet drugs and generation of thrombin in clotting blood.[J].1992,80(8).
[30]Ekstr?m,M.P.,Hermansson,A.B.,Str?m,K.E..Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease: A time-dependent analysis[J].2013,187(7).
[31]Mariana, Mu?oz-Esquerre,José Luis, Ferreiro,Daniel, Huertas,etc.Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients.[J].2018,13(Spec ).
[32]Solheim S,Pettersen AA,Arnesen H,etc.No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease.[J].2006,96(5).
[33]Fawzy, Ashraf,Putcha, Nirupama,Aaron, Carrie P.,etc.Aspirin Use and Respiratory Morbidity in COPD A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study[J].2019,155(3).
[34]Kirkham,P.A.,Barnes,P.J..Oxidative stress in COPD[J].2013,144(1).
[35]Pavasini, Rita,Biscaglia, Simone,d'Ascenzo, Fabrizio,etc.Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis[J].2016,13(4).
[36]Barnes, Peter J..Inflammatory mechanisms in patients with chronic obstructive pulmonary disease[J].2016,138(1).
[37]Adam J, Bia?as,Claudio, Pedone,Wojciech J, Piotrowski,etc.Platelet distribution width as a prognostic factor in patients with COPD - pilot study.[J].2017,12(Spec ).
[38]Angelo Zinellu,Panagiotis Paliogiannis,Elisabetta Sotgiu,etc.Platelet Count and Platelet Indices in Patients with Stable and Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis[J].2021,18(2).